High Response Rate for Treatment With Gemtuzumab Ozogamicin and Cytarabine in Elderly Patients With Acute Myeloid Leukemia and Favorable and Intermediate-I Cytogenetic Risk
Sigal Tavor, Einam Rahamim, Nadav Sarid, Uri Rozovski, Lili Gibstein, Freddy Aviv, Ilya Kirsner, Elizabeth NaparstekVolume:
12
Year:
2012
Language:
english
DOI:
10.1016/j.clml.2012.05.007
File:
PDF, 313 KB
english, 2012